Long-term therapy for a chronic disease
Help your MPS VI patient adhere to NAGLAZYME®(galsulfase) therapy
Like treatments for other chronic illnesses, patients must receive regular and consistent NAGLAZYME infusions to derive benefit from treatment. That’s why it is essential to proactively address issues that may affect long-term treatment adherence, including:
- Difficulty keeping infusion appointments due to work/school obligations or disease complications
- Anxiety due to painful IV experiences
- Transportation and other issues
- Inexperience or lack of understanding by caregivers about caring for chronic conditions
The role of a multidisciplinary team is not only to prescribe and treat patients but may also be to become an advocate for their patients.17 Indeed, research suggests that the social isolation that often accompanies chronic illness can lead to emotional and psychological stress, dysfunction, and compliance issues.18
Adherence also depends on managing patient and caregiver expectations as well as providing assistance with accessing other available resources.
Next: Consequences of noncompliance